Exagen Inc. (NASDAQ:XGN) Q4 2020 Earnings Conference Call March 16, 2021 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations, Managing Director at Westwicke Partners Ron Rocca - President, Chief Executive Officer Kamal Adawi - Chief Financial Officer Mark Hazeltine - Chief Operating Officer Conference Call Participants Chris Lin - Cowen and Company Brian Weinstein - William Blair Kyle Mikson - Cantor Fitzgerald Vidyun Bais - BTIG Paul Knight - KeyBank Operator Greetings, ladies and gentlemen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 001-39049 EXAGEN INC. (Exact name of registrant as specified in its charter) Delaware 20-0434866 (State or other jurisdiction of incorpor ...

Investor Presentation Q3 2020 January 30, 2019 Draft v1 Disclaimer This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, the impact of the COVID-19 pandemic, current and future product offerings, reimbursement and coverage, our ability to implement an integrated testing with therapeutics strategy, the expected ben ...

Exagen Inc. (NASDAQ:XGN) Q3 2020 Results Conference Call November 10, 2020 4:30 PM ET Company Participants Mike Cavanaugh - IR Ron Rocca - President and CEO Kamal Adawi - CFO Mark Hazeltine - SVP, Finance & Corporate Development Conference Call Participants Chris Lin - Cowen Kyle Mikson - Cantor Fitzgerald Mark Messaro - BTIG Paul Knight - KeyBanc Capital Markets Operator Good afternoon, and welcome to the Exagen Inc. Third Quarter 2020 Earnings Call. [Operator Instructions] As a reminder, this conference i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39049 EXAGEN INC. (Exact name of registrant as specified in its charter) Delaware 20-0434866 (State or other jurisdiction of incorporation or organization) 1261 ...

Exagen Inc. (NASDAQ:XGN) Q2 2020 Earnings Conference Call July 28, 2020 ET Company Participants Ron Rocca - President and Chief Executive Officer Kamal Adawi - Chief Financial Officer Mark Hazeltine - Senior Vice President of Finance & Corporate Development Conference Call Participants Chris Lin - Cowen Brian Weinstein - William Blair Kyle Mikson - Cantor Fitzgerald Mark Massaro - BTIG Operator Greetings, and welcome to the Exagen Inc. Second Quarter 2020 Earnings Call. [Operator Instructions]. I would now ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39049 EXAGEN INC. (Exact name of registrant as specified in its charter) Delaware 20-0434866 (State or other jurisdiction of incorporation or organization) 1261 Libe ...

Exagen Inc. (NASDAQ:XGN) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Mark Hazeltine - Senior Vice President of Finance & Corporate Development Ron Rocca - President & Chief Executive Officer Kamal Adawi - Chief Financial Officer Conference Call Participants Brian Weinstein - William Blair Kyle Mikson - Cantor Fitzgerald Operator Greetings, and welcome to the Exigen Quarter One 2020 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answe ...

Corporate presentation As of March 31, 2020 nasdaq: axgn axogen® Safe harbor statement This presentation contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or predictions of future conditions, events, or results based on various assumptions and management's estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as "expects," ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-39049 EXAGEN INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 1261 Liberty Way, Suite C Vi ...